High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-weighted MR Images: Relationship with Increasing Cumulative Dose of a Gadolinium-based Contrast Material
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
PURPOSE: To explore any correlation between the number of previous gadolinium-based contrast material administrations and high signal intensity (SI) in the dentate nucleus and globus pallidus on unenhanced T1-weighted magnetic resonance (MR) images. MATERIALS AND METHODS: The institutional review board approved this study, waiving the requirement to obtain written informed consent. A group of 381 consecutive patients who had undergone brain MR imaging was identified for cross-sectional analysis. For longitudinal analysis, 19 patients who had undergone at least six contrast-enhanced examinations were compared with 16 patients who had undergone at least six unenhanced examinations. The mean SIs of the dentate nucleus, pons, globus pallidus, and thalamus were measured on unenhanced T1-weighted images. The dentate nucleus-to-pons SI ratio was calculated by dividing the SI in the dentate nucleus by that in the pons, and the globus pallidus-to-thalamus SI ratio was calculated by dividing the SI in the globus pallidus by that in the thalamus. Stepwise regression analysis was undertaken in the consecutive patient group to detect any relationship between the dentate nucleus-to-pons or globus pallidus-to-thalamus SI ratio and previous gadolinium-based contrast material administration or other factors. A random coefficient model was used to evaluate for longitudinal analysis. RESULTS: The dentate nucleus-to-pons SI ratio showed a significant correlation with the number of previous gadolinium-based contrast material administrations (P < .001; regression coefficient, 0.010; 95% confidence interval [CI]: 0.009, 0.011; standardized regression coefficient, 0.695). The globus pallidus-to-thalamus SI ratio showed a significant correlation with the number of previous gadolinium-based contrast material administrations (P < .001; regression coefficient, 0.004; 95% CI: 0.002, 0.006; standardized regression coefficient, 0.288), radiation therapy (P = .009; regression coefficient, -0.014; 95% CI: -0.025, -0.004; standardized regression coefficient, -0.151), and liver function (P = .031; regression coefficient, 0.023; 95% CI: 0.002, 0.044; standardized regression coefficient, 0.107). The dentate nucleus-to-pons and globus pallidus-to-thalamus SI ratios in patients who had undergone contrast-enhanced examinations were significantly greater than those of patients who had undergone unenhanced examinations (P < .001 for both). CONCLUSION: High SI in the dentate nucleus and globus pallidus on unenhanced T1-weighted images may be a consequence of the number of previous gadolinium-based contrast material administrations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
White, G. W., Gibby, W. A., & Tweedle, M. F. (2006) · Investigative Radiology · doi:10.1097/01.rli.0000186569.32408.95 · Cited by 362
MR Imaging Findings in Hepatic Encephalopathy
Rovira, A., Alonso, J., & Córdoba, J. (2008) · American Journal of Neuroradiology · doi:10.3174/ajnr.a1139 · Cited by 358
MRI contrast agents: Basic chemistry and safety
Hao, D., Ai, T., Goerner, F., Hu, X., Runge, V. M., & Tweedle, M. (2012) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.23725 · Cited by 336
Physicochemical Properties of Gadoteridol and Other Magnetic Resonance Contrast Agents
Tweedle, M. F. (1992) · Investigative Radiology · doi:10.1097/00004424-199208001-00002 · Cited by 158
Kim, T. J., Kim, I. O., Kim, W. S., Cheon, J., Moon, S.-Y., Kwon, J. W., Seo, J. K., & Yeon, K. M. (2006) · PubMed · Cited by 151
Roccatagliata, L., Vuolo, L., Bonzano, L., Pichiecchio, A., & Mancardi, G. (2009) · Radiology · doi:10.1148/radiol.2511081269 · Cited by 106
Identification of mineral deposits in the brain on radiological images: a systematic review
Hernández, M. D. C. V., Maconick, L. C., Tan, M. J. E., & Wardlaw, J. M. (2012) · European Radiology · doi:10.1007/s00330-012-2494-2 · Cited by 70
Shin, Y. C., Kim, E.-A. L., Cheong, H., Cho, S., Sakong, J., Kim, K., Yang, J. S., Jin, Y.-W., Kang, S., & Kim, Y. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.03.014 · Cited by 57
Cited by
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
Wahsner, J., Gale, E. M., Rodríguez-Rodríguez, A., & Caravan, P. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00363 · Cited by 1,603
Intracranial gadolinium deposition after contrast-enhanced MR imaging
McDonald, R. J., McDonald, J. S., Kallmes, D. F., Jentoft, M. E., Murray, D. L., Thielen, K. R., Williamson, E. E., & Eckel, L. J. (2015) · Radiology · doi:10.1148/radiol.15150025 · Cited by 1,358
Kanda, T., Fukusato, T., Matsuda, M., Toyoda, K., Oba, H., Kotoku, J., Haruyama, T., Kitajima, K., & Furui, S. (2015) · Radiology · doi:10.1148/radiol.2015142690 · Cited by 874
Self-citationGadolinium deposition in the brain: summary of evidence and recommendations
Gulani, V., Calamante, F., Shellock, F. G., Kanal, E., & Reeder, S. B. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30158-8 · Cited by 784
Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms
Rogosnitzky, M., & Branch, S. (2016) · BioMetals · doi:10.1007/s10534-016-9931-7 · Cited by 766
Radbruch, A., Weberling, L. D., Kieslich, P. J., Eidel, O., Burth, S., Kickingereder, P., Heiland, S., Wick, W., Schlemmer, H.-P., & Bendszus, M. (2015) · Radiology · doi:10.1148/radiol.2015150337 · Cited by 561
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Brain-wide glymphatic enhancement and clearance in humans assessed with MRI.
Ringstad, G., Valnes, L. M., Dale, A. M., Pripp, A. H., Vatnehol, S.-A. S., Emblem, K. E., Mardal, K.-A., & Eide, P. K. (2018) · JCI Insight · doi:10.1172/jci.insight.121537 · Cited by 533
“Gadolinium accumulation in the brain after multiple intravenous administrations has been a major concern since it was first reported in 2014 (61).”
Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome
Kratz, C. P., Achatz, M. I., Brugières, L., Frebourg, T., Garber, J. E., Greer, M.-L. C., Hansford, J. R., Janeway, K. A., Kohlmann, W. K., McGee, R., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0408 · Cited by 534
Clinical intravoxel incoherent motion and diffusion MR imaging: Past, present, and future
Iima, M., & Le Bihan, D. (2016) · Radiology · doi:10.1148/radiol.2015150244 · Cited by 498
What can we see with IVIM MRI?
Le Bihan, D. (2019) · NeuroImage · doi:10.1016/j.neuroimage.2017.12.062 · Cited by 498
Akers, A., Al-Shahi Salman, R., A. Awad, I., Dahlem, K., Flemming, K., Hart, B., Kim, H., Jusue-Torres, I., Kondziolka, D., Lee, C., et al. (2017) · Neurosurgery · doi:10.1093/neuros/nyx091 · Cited by 495
Jeon, M., Halbert, M. V., Stephen, Z. R., & Zhang, M. (2021) · Advanced Materials · doi:10.1002/adma.201906539 · Cited by 477
Comstock, C. E., Gatsonis, C., Newstead, G. M., Snyder, B. S., Gareen, I. F., Bergin, J. T., Rahbar, H., Sung, J. S., Jacobs, C., Harvey, J. A., et al. (2020) · JAMA · doi:10.1001/jama.2020.0572 · Cited by 456
Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update
Ramalho, J., Semelka, R. C., Ramalho, M., Nunes, R. H., AlObaidy, M., & Castillo, M. (2016) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4615 · Cited by 453
Errante, Y., Cirimele, V., Mallio, C. A., Di Lazzaro, V., Zobel, B. B., & Quattrocchi, C. C. (2014) · Investigative Radiology · doi:10.1097/rli.0000000000000072 · Cited by 421
25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives
Lohrke, J., Frenzel, T., Endrikat, J., Alves, F. C., Grist, T. M., Law, M., Lee, J. M., Leiner, T., Li, K.-C., Nikolaou, K., et al. (2016) · Advances in Therapy · doi:10.1007/s12325-015-0275-4 · Cited by 420
Murata, N., Gonzalez-Cuyar, L. F., Murata, K., Fligner, C., Dills, R., Hippe, D., & Maravilla, K. R. (2016) · Investigative Radiology · doi:10.1097/rli.0000000000000252 · Cited by 408
Gadolinium‐based contrast agents: A comprehensive risk assessment
Fraum, T. J., Ludwig, D. R., Bashir, M. R., & Fowler, K. J. (2017) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25625 · Cited by 402
Deep learning enables reduced gadolinium dose for contrast-enhanced brain MRI
Gong, E., Pauly, J. M., Wintermark, M., & Zaharchuk, G. (2018) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25970 · Cited by 351
A Manganese Alternative to Gadolinium for MRI Contrast
Gale, E. M., Atanasova, I. P., Blasi, F., Ay, I., & Caravan, P. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b10748 · Cited by 353
McDonald, R. J., McDonald, J. S., Kallmes, D. F., Jentoft, M. E., Paolini, M. A., Murray, D. L., Williamson, E. E., & Eckel, L. J. (2017) · Radiology · doi:10.1148/radiol.2017161595 · Cited by 318
Inorganic nanoparticles in clinical trials and translations
Huang, H., Feng, W., Chen, Y., & Shi, J. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100972 · Cited by 283
Robert, P., Lehericy, S., Grand, S., Violas, X., Fretellier, N., Idée, J.-M., Ballet, S., & Corot, C. (2015) · Investigative Radiology · doi:10.1097/rli.0000000000000181 · Cited by 257
Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution
Do, C., DeAguero, J., Brearley, A., Trejo, X., Howard, T., Escobar, G. P., & Wagner, B. (2020) · Kidney360 · doi:10.34067/kid.0000272019 · Cited by 125
Aram, E., Moeni, M., Abedizadeh, R., Sabour, D., Sadeghi-Abandansari, H., Gardy, J., & Hassanpour, A. (2022) · Nanomaterials · doi:10.3390/nano12203567 · Cited by 66
Hsu, J. C., Naha, P. C., Lau, K. C., Chhour, P., Hastings, R., Moon, B. F., Stein, J. M., Witschey, W. R. T., McDonald, E. S., Maidment, A. D. A., et al. (2018) · Nanoscale · doi:10.1039/c8nr03741h · Cited by 63
“More recently, gadolinium based contrast agents for MRI were found to accumulate in neural tissues even in subjects with normal renal function and remain there for a long time.(8-11) The health effects from long-term retention of gadolinium in the brain are currently unknown.”
BackgroundZschiesche, L., Janko, C., Friedrich, B., Frey, B., Band, J., Lyer, S., Alexiou, C., & Unterweger, H. (2022) · Nanomaterials · doi:10.3390/nano13010014 · Cited by 14
Metadata
- Authors
- Kanda, T., Ishii, K., Kawaguchi, H., Kitajima, K., & Takenaka, D.
- Venue
- Radiology
- Published
- 2014-03
- Volume
- 270
- Issue
- 3
- Pages
- 834-841
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2140036864
- Cited by
- 1,339
- References
- 8
- FWCI
- 43.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.